Earable Neuroscience Inc.
- Industry
- Health Care, Neuroscience, Wearables
- Founded Year
- 2018
- Headquarters
- Boulder, Colorado, USA
- Employee Count
- 51
Key People
- Tam Vu - Founder and CEO
-
Kimi Doan - Chief Innovation Officer
Email: kimi@earable.ai
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises experienced professionals with over a decade in their respective fields.
The leadership's background suggests a strong foundation for navigating the complexities of the medtech industry.
- Clinical Need
-
Aspect: Strong
Summary: The product addresses a significant need in sleep improvement and cognitive enhancement.
With increasing awareness of sleep's impact on overall health, the product meets a pressing clinical need.
- Competition
-
Aspect: Somewhat crowded
Summary: The market has several players, but the product offers unique features.
While the market is competitive, the product's unique features may provide a competitive edge.
- Technical Challenge
-
Aspect: Moderate
Summary: The technology involves moderate complexity with manageable risks.
The integration of AI and wearable technology presents challenges, but they are within the team's capabilities.
- Patent
-
Aspect: Very Strong
Summary: The company holds 15 global patents, indicating strong intellectual property.
The extensive patent holdings provide a competitive advantage and protect the company's innovations.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding from reputable investors.
Investments from entities like Samsung Ventures and Founders Fund provide the necessary capital for scaling operations.
- Regulatory
-
Aspect: 510k/PMA
Summary: The product is undergoing regulatory processes for market approval.
Compliance with FDA regulations is essential for product launch and market acceptance.
Opportunity Rollup
- Odds of Success
- 3.3
- Peak Market Share
- 4.4
- Segment CAGR
- 4.9%
- Market Segment
- Neurology Devices
- Market Sub Segment
- Sleep Therapy Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.22 |
| 2 | 0.66 |
| 3 | 1.54 |
| 4 | 3.08 |
| 5 | 4.40 |
Key Takeaway
Earable Neuroscience's FRENZ Brainband addresses a significant clinical need with strong IP and funding, but must navigate a competitive market and regulatory challenges.